Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

Jon Salmanton-García; Francesco Marchesi; Andreas Glenthøj; Yavuz M. Bilgin; Jens Van Praet; Julio Dávila-Valls; Sonia Martín-Pérez; Jorge Labrador; Jaap Van Doesum; Iker Falces-Romero; Francesca Farina; Martin Schönlein; Mathilde Chanut; Verena Petzer; Ildefonso Espigado; Michelina Dargenio; Avinash Aujayeb; Uluhan Sili; Laura Serrano; László Imre Pinczés; Nick De Jonge; Andrés Soto-Silva; Caterina Buquicchio; Lucia Prezioso; Monia Marchetti; Stef Meers; Alessandro Busca; Paolo Corradini; Martin Hoenigl; Philipp Koehler; Laman Rahimli; Gökçe Melis Çolak; Elena Arellano; Dominik Wolf; Stefanie Gräfe; Emanuele Ammatuna; Caroline Berg Venemyr; Oliver A. Cornely; Livio Pagano

doi:10.1097/HS9.0000000000000789

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report

Jon Salmanton-García^*, Francesco Marchesi, Andreas Glenthøj, Yavuz M. Bilgin, Jens Van Praet, Julio Dávila-Valls, Sonia Martín-Pérez, Jorge Labrador, Jaap Van Doesum, Iker Falces-Romero, Francesca Farina, Martin Schönlein, Mathilde Chanut, Verena Petzer, Ildefonso Espigado, Michelina Dargenio, Avinash Aujayeb, Uluhan Sili, Laura Serrano, László Imre PinczésNick De Jonge, Andrés Soto-Silva, Caterina Buquicchio, Lucia Prezioso, Monia Marchetti, Stef Meers, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Philipp Koehler, Laman Rahimli, Gökçe Melis Çolak, Elena Arellano, Dominik Wolf, Stefanie Gräfe, Emanuele Ammatuna, Caroline Berg Venemyr, Oliver A. Cornely, Livio Pagano

^*Corresponding author for this work

Research output: Contribution to journal › Letter › Academic › peer-review

29 Citations (Scopus)

183 Downloads (Pure)

Original language	English
Article number	E789
Number of pages	4
Journal	HemaSphere
Volume	6
Issue number	11
DOIs	https://doi.org/10.1097/HS9.0000000000000789
Publication status	Published - 25-Nov-2022

Access to Document

10.1097/HS9.0000000000000789Licence: CC BY

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 VaccineFinal publisher's version, 298 KBLicence: CC BY

Handle.net

Persistent link

Cite this

Salmanton-García, J., Marchesi, F., Glenthøj, A., Bilgin, Y. M., Van Praet, J., Dávila-Valls, J., Martín-Pérez, S., Labrador, J., Van Doesum, J., Falces-Romero, I., Farina, F., Schönlein, M., Chanut, M., Petzer, V., Espigado, I., Dargenio, M., Aujayeb, A., Sili, U., Serrano, L., ... Pagano, L. (2022). Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. HemaSphere, 6(11), Article E789. https://doi.org/10.1097/HS9.0000000000000789

@article{cbcae854acbc4cb9a02677d7638ab243,

title = "Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report",

author = "Jon Salmanton-Garc{\'i}a and Francesco Marchesi and Andreas Glenth{\o}j and Bilgin, {Yavuz M.} and {Van Praet}, Jens and Julio D{\'a}vila-Valls and Sonia Mart{\'i}n-P{\'e}rez and Jorge Labrador and {Van Doesum}, Jaap and Iker Falces-Romero and Francesca Farina and Martin Sch{\"o}nlein and Mathilde Chanut and Verena Petzer and Ildefonso Espigado and Michelina Dargenio and Avinash Aujayeb and Uluhan Sili and Laura Serrano and Pincz{\'e}s, {L{\'a}szl{\'o} Imre} and {De Jonge}, Nick and Andr{\'e}s Soto-Silva and Caterina Buquicchio and Lucia Prezioso and Monia Marchetti and Stef Meers and Alessandro Busca and Paolo Corradini and Martin Hoenigl and Philipp Koehler and Laman Rahimli and {\c C}olak, {G{\"o}k{\c c}e Melis} and Elena Arellano and Dominik Wolf and Stefanie Gr{\"a}fe and Emanuele Ammatuna and {Berg Venemyr}, Caroline and Cornely, {Oliver A.} and Livio Pagano",

note = "Funding Information: EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223). The funder of the study had no role in study design, data analysis, interpretation, or writing of the report. All authors had full access to the data and had final responsibility for the decision to submit for publication.",

year = "2022",

month = nov,

day = "25",

doi = "10.1097/HS9.0000000000000789",

language = "English",

volume = "6",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

Salmanton-García, J, Marchesi, F, Glenthøj, A, Bilgin, YM, Van Praet, J, Dávila-Valls, J, Martín-Pérez, S, Labrador, J, Van Doesum, J, Falces-Romero, I, Farina, F, Schönlein, M, Chanut, M, Petzer, V, Espigado, I, Dargenio, M, Aujayeb, A, Sili, U, Serrano, L, Pinczés, LI, De Jonge, N, Soto-Silva, A, Buquicchio, C, Prezioso, L, Marchetti, M, Meers, S, Busca, A, Corradini, P, Hoenigl, M, Koehler, P, Rahimli, L, Çolak, GM, Arellano, E, Wolf, D, Gräfe, S, Ammatuna, E, Berg Venemyr, C, Cornely, OA & Pagano, L 2022, 'Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report', HemaSphere, vol. 6, no. 11, E789. https://doi.org/10.1097/HS9.0000000000000789

TY - JOUR

T1 - Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine

T2 - An EPICOVIDEHA Report

AU - Salmanton-García, Jon

AU - Marchesi, Francesco

AU - Glenthøj, Andreas

AU - Bilgin, Yavuz M.

AU - Van Praet, Jens

AU - Dávila-Valls, Julio

AU - Martín-Pérez, Sonia

AU - Labrador, Jorge

AU - Van Doesum, Jaap

AU - Falces-Romero, Iker

AU - Farina, Francesca

AU - Schönlein, Martin

AU - Chanut, Mathilde

AU - Petzer, Verena

AU - Espigado, Ildefonso

AU - Dargenio, Michelina

AU - Aujayeb, Avinash

AU - Sili, Uluhan

AU - Serrano, Laura

AU - Pinczés, László Imre

AU - De Jonge, Nick

AU - Soto-Silva, Andrés

AU - Buquicchio, Caterina

AU - Prezioso, Lucia

AU - Marchetti, Monia

AU - Meers, Stef

AU - Busca, Alessandro

AU - Corradini, Paolo

AU - Hoenigl, Martin

AU - Koehler, Philipp

AU - Rahimli, Laman

AU - Çolak, Gökçe Melis

AU - Arellano, Elena

AU - Wolf, Dominik

AU - Gräfe, Stefanie

AU - Ammatuna, Emanuele

AU - Berg Venemyr, Caroline

AU - Cornely, Oliver A.

AU - Pagano, Livio

N1 - Funding Information: EPICOVIDEHA has received funds from Optics COMMITTM (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223). The funder of the study had no role in study design, data analysis, interpretation, or writing of the report. All authors had full access to the data and had final responsibility for the decision to submit for publication.

PY - 2022/11/25

Y1 - 2022/11/25

U2 - 10.1097/HS9.0000000000000789

DO - 10.1097/HS9.0000000000000789

M3 - Letter

AN - SCOPUS:85143836045

SN - 2572-9241

VL - 6

JO - HemaSphere

JF - HemaSphere

IS - 11

M1 - E789

ER -